tm
Seeing Is Believing
tm
Seeing Is Believing
Clarus Therapeutics Holdings's activity chart (see below) currently has 3 price targets and 7 ratings on display.
Most recent stock forecast was given by from NEEDHAM on 23-Aug-2022. First documented stock forecast 20-Sep-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2021
$3
3 years 10 months 16 days ago
(23-Aug-2022)
0/2 (0%)
$2.55 (566.67%)
Hold Since 22-Aug-2022
$13
3 years 10 months 17 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy Since 14-Oct-2021
$10
4 years 1 months 22 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy Since 20-Sep-2021
$12
$11.98 (59900.00%)
4 years 9 months 19 days ago
(20-Sep-2021)
0/1 (0%)
$3.86 (47.42%)
Buy Since 20-Sep-2021
$20
$19.98 (99900.00%)
4 years 9 months 19 days ago
(20-Sep-2021)
0/1 (0%)
$11.86 (145.70%)
What is CRXT (Clarus Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on CRXT (Clarus Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on CRXT (Clarus Therapeutics Holdings)?
Which analyst is the currently most bullish on CRXT (Clarus Therapeutics Holdings)?
Which analyst is the currently most reserved on CRXT (Clarus Therapeutics Holdings)?
